What is the white-coat effect and how should it be measured?

被引:108
作者
Pickering, TG
Gerin, W
Schwartz, AR
机构
[1] Mt Sinai Med Ctr, Integrat & Behav Cardiovasc Hlth Program, New York, NY 10029 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
关键词
white-coat hypertension; ambulatory blood pressure monitoring; self-monitoring; reactivity;
D O I
10.1097/00126097-200212000-00001
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The white coat effect is conceived as a measure of the blood pressure response to a clinic visit, but there is no agreement as to exactly how it should be defined. The most widely used definition is the difference between the average clinic and daytime ambulatory blood pressures, but other methods that have been used include the difference between clinic and home pressures, measurements using ambulatory blood pressures only, clinic measurements only, and laboratory (reactivity) testing. Few studies have compared the different methods, but the reactivity method has reported bigger changes of blood pressure and heart rate than the others. The effect tends to be greater in older than younger patients, in women than in men, but is present to a greater or lesser degree in almost all hypertensive patients. It is diminished but not obliterated by drug treatment. It is not closely related to overall blood pressure variability, and does not predict cardiovascular risk. The white coat effect appears to be idiosyncratic to the clinic setting. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 47 条
[1]   PSYCHOPHYSIOLOGICAL REACTIVITY AND CARDIAC END-ORGAN CHANGES IN WHITE COAT HYPERTENSION [J].
CARDILLO, C ;
DEFELICE, F ;
CAMPIA, U ;
FOLLI, G .
HYPERTENSION, 1993, 21 (06) :836-844
[2]  
DEVEREUX RB, 1993, AM J HYPERTENS, V6, pS211
[3]   Is the 'clinic-home blood pressure difference' associated with psychological distress? A primary care-based study [J].
DonnerBanzhoff, N ;
Chan, Y ;
Szalai, JP ;
Hilditch, JR .
JOURNAL OF HYPERTENSION, 1997, 15 (06) :585-590
[4]   MAGNITUDE, REPRODUCIBILITY, AND COMPONENTS OF THE PRESSOR-RESPONSE TO THE CLINIC [J].
ELIJOVICH, F ;
LAFFER, CL .
HYPERTENSION, 1990, 15 (02) :I161-I165
[5]   Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension [J].
Fagard, RH ;
Staessen, JA ;
Thijs, L ;
Gasowski, J ;
Bulpitt, CJ ;
Clement, D ;
de Leeuw, PW ;
Dobovisek, J ;
Jääskivi, M ;
Leonetti, G ;
O'Brien, E ;
Palatini, P ;
Parati, G ;
Rodicio, JL ;
Vanhanen, H ;
Webster, J .
CIRCULATION, 2000, 102 (10) :1139-1144
[6]  
FLORAS JS, 1981, LANCET, V2, P107
[7]  
Fogari, 1996, Blood Press Monit, V1, P51
[8]   24-Hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring [J].
Fogari, R ;
Ambrosoli, S ;
Corradi, L ;
Esposti, ED ;
Mos, L ;
Nami, R ;
Nicrosini, F ;
Pessina, AC ;
Salvetti, A ;
Vaccarella, A ;
Zanchetti, A ;
Martin, A ;
Reeves, RA .
JOURNAL OF HYPERTENSION, 1997, 15 (12) :1511-1518
[9]   MEASUREMENT RELIABILITY OF CARDIOVASCULAR REACTIVITY CHANGE SCORES - A COMPARISON OF INTERMITTENT AND CONTINUOUS METHODS OF ASSESSMENT [J].
GERIN, W ;
PIEPER, C ;
PICKERING, TG .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1993, 37 (05) :493-501
[10]   WHITE COAT HYPERTENSION - NO HARM FOR THE HEART [J].
GOSSE, P ;
PROMAX, H ;
DURANDET, P ;
CLEMENTY, J .
HYPERTENSION, 1993, 22 (05) :766-770